Analysis of survival data in thalassemia patients in Shiraz, Iran
Abdolreza Rajaeefard, Mahmoud Hajipour, Hamid Reza Tabatabaee, Jafar Hassanzadeh, Shahab Rezaeian, Zahra Moradi, Mehdi Sharafi, Mohsen Shafiee, Ali Semati, Sanaz Safaei, Maryam Soltani
Epidemiol Health. 2015;37(0):e2015031  Published online 2015 Jul 7     DOI: https://doi.org/10.4178/epih/e2015031
Citations to this article as recorded by Crossref logo
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine
Rashail Faraon, Mahmoud Daraghmah, Fekri Samarah, Mahmoud A. Srour
BMC Hematology.2019;[Epub]     CrossRef
The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran
Alireza Ansari-Moghaddam, Hossein Ali Adineh, Iraj Zareban, Mehdi Mohammadi, Mahtab Maghsoodlu
Epidemiology and Health.2018; 40: e2018048.     CrossRef
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Angela Vitrano, Giuseppina Calvaruso, Eliana Lai, Grazia Colletta, Alessandra Quota, Calogera Gerardi, Luciana Concetta Rigoli, Lorella Pitrolo, Liana Cuccia, Francesco Gagliardotto, Aldo Filosa, Vincenzo Caruso, Crocetta Argento, Saveria Campisi, Michele
British Journal of Haematology.2017; 176(1): 124.     CrossRef
Poor quality of life as a predictor of survival among thalassemia patients in Iran
Shahab Rezaeian
Epidemiology and Health.2017; 39: e2017013.     CrossRef